Aileron Therapeutics Inc.

NASDAQ: ALRN · Real-Time Price · USD
2.11
0.18 (9.33%)
At close: Jan 10, 2025, 10:00 PM

Aileron Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
12.87M 17.31M 5.19M 3.6M
Short-Term Investments
n/a n/a 16.05M 42.33M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
2K 2.19M 24K 24K
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
792K 746K 25K 25K
Total Current Assets
13.66M 18.27M 21.87M 48.18M
Property-Plant & Equipment
1K 19K 110K 280K
Goodwill & Intangibles
48.53M 85.53M n/a n/a
Total Long-Term Assets
48.53M 87.74M 134K 304K
Total Assets
62.19M 106.01M 22.01M 48.48M
Account Payables
911K 1.19M 1.72M 1.21M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 33K 93K
Other Current Liabilities
5.75M 206K 1.17M 1.93M
Total Current Liabilities
5.75M 4.38M 3.38M 4.51M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
277K 91.41M n/a n/a
Total Long-Term Liabilities
2.05M 94.74M 1.75M 69K
Total Liabilities
7.8M 99.12M 3.38M 4.58M
Total Debt
n/a 48K 33K 162K
Common Stock
108K 91K 91K 91K
Retained Earnings
-351.4M -288.52M -272.79M -245.46M
Comprehensive Income
-18K -63K -48K -13K
Shareholders Equity
54.39M 6.89M 18.62M 43.9M
Total Investments
n/a n/a 16.05M 42.33M